| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.32 | 5e-20 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-13 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.31 | 3e-09 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.29 | 4e-09 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.28 | 1e-07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |